Skip to content

e-Masterclass

on on ILD & PAH

on on ILD & PAH

A Collaborative Endeavor by the World Scleroderma Foundation and Panamerican League of Associations for Rheumatology

A Collaborative Endeavor by the World Scleroderma Foundation and Panamerican League of Associations for Rheumatology

Session 1 - Friday, September 11, 2026 - h 19:00-21:00 CET
Session 2 - Friday, October 9, 2026 - h 19:00-21:00 CET
Session 3 - Friday, November 13, 2026 - h 18:00-20:00 CET
Session 4 - Friday, December 11, 2026 - h 18:00-20:00 CET

SCIENTIFIC ORGANIZERS: Marco Matucci-Cerinic, Yannick Allanore, Carlos Enrique Toro Gutierrez

Registration Form

For all four Sessions

SCIENTIFIC ORGANIZERS

allanore

Yannick Allanore

Université Paris Cité, Cochin Hospital, Paris, France

matucci

Marco Matucci Cerinic

Università Vita - Salute San Raffaele Milano, Italy

toro

Carlos Enrique Toro Gutierrez

Systemic Sclerosis Fellow, McMaster University, Canada

Laura Alberti

Hospital de Rehabilitación Respiratoria M. Ferrer, Buenos Aires, Argentina

Julián Barahona Correa

Division of Immunology and Rheumatology, Stanford University, USA

Santiago Bernal Macias

Medical Rheumatologist, Pontificia Universidad Javeriana, Colombia

Luis Javier Cajas Santana

Rheumatologist. National University of Colombia

Karla Chacón

Instituto Nacional de Enfermedades Respiratorias, México

Christopher Denton

University College London and Royal Free Hospital London, UK

Juan Ignacio Enghelmayer

Hospital de Clínicas, University of Buenos Aires, Argentina

Fernanda Godinho de Amorim

Medical Rheumatologist, Paulista School of Medicine

Cristiane Kayzer

Paulista Medical School, Federal University of São Paulo, Brazil

Nader Khalidi

Division Director of Rheumatology, McMaster University, Canada

Dinesh Khanna

University of Michigan, USA

Sandra Fabiana Montoya

Ramos Mejia Hospital, Buenos Aires, Argentina

Janet Pope

University of Western Ontario, Canada

Gerardo Quintana

National University of Colombia

Virginia Rodríguez

University of Medicine, Montevideo, Uruguay

Jorge Rojas Serrano

Instituto Nacional de Enfermedades Respiratorias, México

Manuela Rubio Rivera

Hospital Universitario del Valle, Cali, Colombia

Percival Sampaio Barros

University of São Paulo, Brazil

Gabriela Tabaj

Respiratory physician, Cetrángolo Hospital Buenos Aires, Argentina

Veronica Wolff Cecchi

National Institute of Respiratory Diseases, Santiago, Chile

PRELIMINARY PROGRAMME

Fully virtual online format

Session 1 – Friday, September 11, 2026
Pathophysyology, epidemiology and imaging of ILD & PAH in CTD
11:00–13:00 – Costa Rica, El Salvador, Honduras, Nicaragua
12:00–14:00 – Colombia, Ecuador, Panama, Peru
13:00–15:00 – Canada (Eastern Time), Cuba, Bolivia, Venezuela, Dominican Republic
14:00–16:00 – Argentina, Brazil (Brasília Time), Paraguay, Uruguay
19:00–21:00 CEST – Central European Summer Time (Italy and Central Europe)

Click to view programme

19:00    Session introduction & objectives
• Marco Matucci Cerinic – WSF President – University Vita Salute San Raffael, Milan, Italy
• Carlos Enrique Toro – PANLAR President – Systemic Sclerosis Fellow, McMaster University, Canada
19:05    Pathophysiology of CTD-ILD
• Karla Chacón – Instituto Nacional de Enfermedades Respiratorias, México
19:20    Pathophysiology of CTD-PAH
• Christophe Guignabert – Université Paris-Saclay
19:35    Epidemiology of lung involvement in CTD: parenchyma and vessels
• TBD – University of Lyon
19:50    Burden of disease: mortality, disability in CTD-PAH & CTD-ILD
• Yannick Allanore – Université Paris Cité
20:05    Imaging the parenchyma in CTD-ILD
• Paola Orausclio – Centro de Diagnostico Rossi, Buenos Aires, Argentina.
20:20    Imaging the heart and the vessels in CTD-PAH
• Antonia Maria Valenzuela Vergara – Pontificia Universidad Católica de Chile
20:35    Interactive discussion and questions
• Alejandra Babini – Universidad Nacional de Córdoba, Facultad de Medicina
20:55    Key messages & wrap‑up
• Marco Matucci Cerinic – WSF President – University Vita Salute San Raffael, Milan, Italy
• Carlos Enrique Toro – PANLAR President – Systemic Sclerosis Fellow, McMaster University, Canada
Session 2 – Friday, October 9, 2026
Screening or Missing the Window? Risk Stratification in CTD-ILD
11:00–13:00 – Costa Rica, El Salvador, Honduras, Nicaragua
12:00–14:00 – Colombia, Ecuador, Panama, Peru
13:00–15:00 – Canada (Eastern Time), Cuba, Bolivia, Venezuela, Dominican Republic
14:00–16:00 – Argentina, Brazil (Brasília Time), Paraguay, Uruguay
19:00–21:00 CEST – Central European Summer Time (Italy and Central Europe)

Click to view programme

19:00 Session introduction & learning goals
19:05 Clinical Case 1: Rapidly progressive ILD
19:15 ILD screening strategies across CTD
19:30 Progressive pulmonary fibrosis in CTD
19:40 Clinical Case 2: What do not miss in PAH prognostic evaluation
19:55 PAH screening algorithms in CTD
20:10 PAH tools for follow-up in CTD-PH
20:25 Is exercise testing a good outcome in both ILD and PAH?
20:40 Panel discussion & questions
20:55 Key messages & wrap up
Session 3 – Friday, November 13, 2026
Immunosuppression, Antifibrotics, Vascular Therapies, or All Of Them Together?
10:00–12:00 – Costa Rica, El Salvador, Honduras, Nicaragua
11:00–13:00 – Colombia, Ecuador, Panama, Peru
12:00–14:00 – Canada (Eastern Time), Cuba, Bolivia, Venezuela, Dominican Republic
13:00–15:00 – Argentina, Brazil (Brasília Time), Paraguay, Uruguay
18:00–20:00 CEST – Central European Summer Time (Italy and Central Europe)

Click to view programme

18:00 Opening session: therapeutic paradigms and objectives
18:05 Clinical Case: Patient with ILD, progressing to PAH
18:15 Immunosuppression in ILD: from csDMARD to targeted therapies
18:30 Antifibrotic therapies and CTD-ILD
18:45 Which combination therapy and when in CTD-ILD?
19:00 Should we use the ILD pattern to guide the treatment in CTD?
19:15 Combination therapy standard and emerging therapies in PAH
19:30 Managing overlapping ILD and PAH phenotypes (group 3 PH)
19:45 Panel discussion & questions
19:55 Key messages & wrap up
Session 4 – Friday, December 11, 2026
New Frontiers in CTD Lung Disease: Rehabilitation and Evolving Models of Care
10:00–12:00 – Costa Rica, El Salvador, Honduras, Nicaragua
11:00–13:00 – Colombia, Ecuador, Panama, Peru
12:00–14:00 – Canada (Eastern Time), Cuba, Bolivia, Venezuela, Dominican Republic
13:00–15:00 – Argentina, Brazil (Brasília Time), Paraguay, Uruguay
18:00–20:00 CEST – Central European Summer Time (Italy and Central Europe)

Click to view programme

18:00 Session introduction & objectives
18:05 Clinical Case: Lung trasplantation in CTD-ILD
18:15 Timing for lung transplantation referral
18:30 Oxygen therapy and rehabilitation
18:45 Acute exacerbations and critical care
19:00 Cellular therapy: breakthrough in ILD?
19:15 Clinical trials landscape in CTD ILD and CTD-PAH
19:30 What should include a lung clinic in CTD patients
19:50 Key messages & course synthesis

This e-Masterclass is supported by a medical education grant of